![Mikio Kawahara](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mikio Kawahara
Chief Investment Officer bei
UTokyo Innovation Platform Co.,Ltd.
Profil
Mikio Kawahara currently works at AccuRna, Inc., as Director from 2017, Braizon Therapeutics, Inc., as Outside Director from 2018, Adriakaim, Inc., as Outside Director from 2020, Fimecs, Inc., as Outside Director from 2020, and UTokyo Innovation Platform Co.,Ltd., as Partner and Chief Investment Officer from 2016.
Aktive Positionen von Mikio Kawahara
| Unternehmen | Position | Beginn |
|---|---|---|
AccuRna, Inc.
 AccuRna, Inc. BiotechnologyHealth Technology Researches and develops nucleic acid-based drugs using drug delivery system technologies | Direktor/Vorstandsmitglied | 01.12.2017 |
Fimecs, Inc.
 Fimecs, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of new drugs whose mechanism is induction of proteolysis | Direktor/Vorstandsmitglied | 01.01.2020 |
UTokyo Innovation Platform Co.,Ltd.
 UTokyo Innovation Platform Co.,Ltd. Investment ManagersFinance UTokyo IPC is an active manger which targets companies of University of Tokyo origin. It provides equity for pre-seed, seed and early-stages capital requirements. | Chief Investment Officer | 01.01.2016 |
Braizon Therapeutics, Inc.
 Braizon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing drugs | Direktor/Vorstandsmitglied | 01.08.2018 |
Adriakaim, Inc.
 Adriakaim, Inc. Medical SpecialtiesHealth Technology Manufactures and sells medical and health-related equipment & provides management and technology strategy consulting services | Direktor/Vorstandsmitglied | 01.05.2020 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
30
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
AccuRna, Inc.
AccuRna, Inc. BiotechnologyHealth Technology Researches and develops nucleic acid-based drugs using drug delivery system technologies | Health Technology |
UTokyo Innovation Platform Co.,Ltd.
UTokyo Innovation Platform Co.,Ltd. Investment ManagersFinance UTokyo IPC is an active manger which targets companies of University of Tokyo origin. It provides equity for pre-seed, seed and early-stages capital requirements. | Finance |
Braizon Therapeutics, Inc.
Braizon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing drugs | Commercial Services |
Adriakaim, Inc.
Adriakaim, Inc. Medical SpecialtiesHealth Technology Manufactures and sells medical and health-related equipment & provides management and technology strategy consulting services | Health Technology |
Fimecs, Inc.
Fimecs, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of new drugs whose mechanism is induction of proteolysis | Commercial Services |
